Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.21% |
| 2 | Financials | 14.63% |
| 3 | Healthcare | 13.11% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
West Bancorporation
WTBA
$502M
| $797K | ﹤0.01% |
37,526
+1,486
| +4% | +$31.5K |
|
2652
Amerant Bancorp
AMTB
$1.15B
| $794K | ﹤0.01% |
+40,270
| New | +$709K |
|
2653
Clarus
CLAR
$136M
| $792K | ﹤0.01% |
55,031
+6,249
| +13% | +$83.3K |
|
2654
OrthoPediatrics
KIDS
$604M
| $791K | ﹤0.01% |
20,258
+2,476
| +14% | +$99.8K |
|
|
CDMO
2655
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $789K | ﹤0.01% |
140,734
+37,480
| +36% | +$155K |
|
2656
Citizens & Northern Corp
CZNC
$466M
| $780K | ﹤0.01% |
29,606
+967
| +3% | +$26.3K |
|
|
PCMI
2657
DELISTED
PCM, Inc
PCMI
| $778K | ﹤0.01% |
+22,203
| New | +$655K |
|
|
AMBR
2658
DELISTED
Amber Road Inc
AMBR
| $778K | ﹤0.01% |
59,517
-204,638
| -77% | -$2.3M |
|
2659
Business First Bancshares
BFST
$1.01B
| $776K | ﹤0.01% |
30,487
+5,177
| +20% | +$129K |
|
2660
Xeris Biopharma Holdings
XERS
$1.42B
| $774K | ﹤0.01% |
67,583
+13,956
| +26% | +$147K |
|
2661
Arcus Biosciences
RCUS
$3.14B
| $773K | ﹤0.01% |
97,127
-1,609
| -2% | -$16.1K |
|
|
ARA
2662
DELISTED
American Renal Associates Holdings, Inc
ARA
| $773K | ﹤0.01% |
103,891
+23,760
| +30% | +$157K |
|
2663
PAR Technology
PAR
$666M
| $767K | ﹤0.01% |
27,178
+1,099
| +4% | +$28.3K |
|
|
RNET
2664
DELISTED
RigNet, Inc.
RNET
| $766K | ﹤0.01% |
75,961
+972
| +1% | +$8.97K |
|
|
ORC
2665
Orchid Island Capital
ORC
$1.19B
| $765K | ﹤0.01% |
24,033
+2,098
| +10% | +$68.1K |
|
2666
Artesian Resources
ARTNA
$362M
| $761K | ﹤0.01% |
20,461
+889
| +5% | +$32.3K |
|
|
ALBO
2667
DELISTED
Albireo Pharma Inc
ALBO
| $761K | ﹤0.01% |
23,576
+3,136
| +15% | +$105K |
|
|
SNCR
2668
DELISTED
Synchronoss Technologies
SNCR
| $756K | ﹤0.01% |
10,608
+8,846
| +502% | +$499K |
|
2669
Intrepid Potash
IPI
$514M
| $751K | ﹤0.01% |
22,336
| – | – |
|
2670
Metropolitan Bank Holding Corp
MCB
$1.11B
| $747K | ﹤0.01% |
16,965
+1,090
| +7% | +$43.4K |
|
|
CTO
2671
CTO Realty Growth
CTO
$776M
| $745K | ﹤0.01% |
45,954
+10,588
| +30% | +$173K |
|
2672
i3 Verticals
IIIV
$265M
| $744K | ﹤0.01% |
25,253
+4,723
| +23% | +$117K |
|
|
DSPG
2673
DELISTED
DSP Group Inc
DSPG
| $741K | ﹤0.01% |
+51,599
| New | +$744K |
|
2674
Blue Bird Corp
BLBD
$1.95B
| $740K | ﹤0.01% |
37,582
+1,291
| +4% | +$23.6K |
|
|
TLRA
2675
DELISTED
Telaria, Inc.
TLRA
| $739K | ﹤0.01% |
98,185
| – | – |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.